Open access
Open access
Powered by Google Translator Translator

Pharmacology/Pharmaceutical Industry

Special Report: The Covid-19 vaccines are a marvel of science. Here’s how we can make the best use of them

3 Dec, 2020 | 08:42h | UTC

The Covid-19 vaccines are a marvel of science. Here’s how we can make the best use of them – STAT

 


Review: Perioperative venous thromboembolism prophylaxis

3 Dec, 2020 | 08:28h | UTC

Perioperative Venous Thromboembolism Prophylaxis – Mayo Clinic Proceedings

 


Opinion: “Put an end to publication by proclamation for Covid vaccines”

2 Dec, 2020 | 07:27h | UTC

Put An End To Publication By Proclamation For Covid Vaccines – Forbes

 


CDC panel moves health workers, nursing home residents to front of COVID vaccine line

2 Dec, 2020 | 07:26h | UTC

CDC panel moves health workers, nursing home residents to front of COVID vaccine line – CIDRAP

See also: Health workers, long-term care facilities should get Covid-19 vaccine first, CDC advisory panel says – STAT

 


Cohort study: Higher dose Z-drug use in dementia is associated with increased fracture and stroke risks, similar or greater to that for higher dose benzodiazepines

1 Dec, 2020 | 08:25h | UTC

Adverse effects of Z-drugs for sleep disturbance in people living with dementia: a population-based cohort study – BMC Medicine

Commentary: The danger of Z-drugs for dementia patients – University of Exeter

 


NICE COVID-19 guideline: Prevention of thromboembolism in patients with COVID-19. “For patients who are having advanced respiratory support: consider increasing pharmacological VTE prophylaxis to an intermediate dose”

1 Dec, 2020 | 08:19h | UTC

COVID-19 rapid guideline: reducing the risk of venous thromboembolism in over 16s with COVID-19 – National Institute for Health and Care Excellence

 


Moderna released more Covid-19 vaccine results. They’re very encouraging.

1 Dec, 2020 | 08:15h | UTC

Moderna released more Covid-19 vaccine results. They’re very encouraging. – Vox

News release: Moderna Announces Primary Efficacy Analysis in Phase 3 COVE Study for Its COVID-19 Vaccine Candidate and Filing Today with U.S. FDA for Emergency Use Authorization

Commentaries: ‘Absolutely remarkable’: No one who got Moderna’s vaccine in trial developed severe COVID-19 – Science AND Moderna to submit Covid-19 vaccine to FDA as full results show 94% efficacy – STAT AND More Good News For Moderna’s COVID-19 Vaccine Candidate – NPR AND Moderna to seek emergency authorization for COVID-19 vaccine – CIDRAP

 

Commentary on Twitter

 


Comprehensive review on the management of pharmaceutical and recreational drug poisoning

1 Dec, 2020 | 08:21h | UTC

Management of pharmaceutical and recreational drug poisoning – Annals of Intensive Care

 


Opinion: Pfizer and Moderna’s “95% effective” vaccines—let’s be cautious and first see the full data

1 Dec, 2020 | 08:13h | UTC

Peter Doshi: Pfizer and Moderna’s “95% effective” vaccines—let’s be cautious and first see the full data – BMJ Opinion

 


Colchicine to be investigated as a possible treatment for COVID-19 in the RECOVERY trial

1 Dec, 2020 | 08:08h | UTC

Colchicine to be investigated as a possible treatment for COVID-19 in the RECOVERY trial – University of Oxford

Commentary: Gout drug Colchicine to be tested as COVID-19 treatment in UK trial – Reuters

 


AstraZeneca vaccine most attractive option for Africa, says WHO – Astra Zeneca CEO says company will run new trial to test more efficient dose

1 Dec, 2020 | 08:05h | UTC

AstraZeneca Vaccine Most Attractive Option For Africa, Says WHO – Astra Zeneca CEO Says Company Will Run New Trial To Test More Efficient Dose – Health Policy Watch

 


Meta-analysis of statins for primary prevention: 100 adults (aged 50-75 years) without known cardiovascular disease would have to be treated for 2.5 years to prevent 1 major adverse cardiovascular event

30 Nov, 2020 | 00:56h | UTC

Evaluation of Time to Benefit of Statins for the Primary Prevention of Cardiovascular Events in Adults Aged 50 to 75 Years: A Meta-analysis – JAMA Internal Medicine (link to abstract – $ for full-text)

Commentary: Time to Benefit of Statins for Primary Prevention of Cardiovascular Events – American College of Cardiology

 

Commentary on Twitter

 


Perspective: “With global push for COVID-19 vaccines, China aims to win friends and cut deals”

27 Nov, 2020 | 08:26h | UTC

With global push for COVID-19 vaccines, China aims to win friends and cut deals – Science

 


India coronavirus: How do you vaccinate a billion people?

27 Nov, 2020 | 08:24h | UTC

India coronavirus: How do you vaccinate a billion people? – BBC

 


Should COVID-19 vaccines be mandatory? Two experts discuss

26 Nov, 2020 | 09:05h | UTC

Should COVID-19 vaccines be mandatory? Two experts discuss – The Conversation

 


Opinion: “The AstraZeneca Covid Vaccine Data Isn’t Up to Snuff”

26 Nov, 2020 | 09:02h | UTC

The AstraZeneca Covid Vaccine Data Isn’t Up to Snuff – Wired

Commentaries: A timeline of the oxford-Astrazeneca Covid-19 vaccine trials – by Hilda Bastian AND After Admitting Mistake, AstraZeneca Faces Difficult Questions About Its Vaccine – The New York Times AND AstraZeneca manufacturing error clouds vaccine study results – Associated Press

 


Meta-analysis: Among the treatment interventions to maintain abstinence from alcohol in primary care, acamprosate was the only intervention with enough evidence of benefit

26 Nov, 2020 | 08:55h | UTC

Treatment interventions to maintain abstinence from alcohol in primary care: systematic review and network meta-analysis – The BMJ

 

Commentary on Twitter

 


Cohort study suggests there is no need to choose first-line drug treatment for hypertension according to age and ethnicity – guidelines could be simplified

26 Nov, 2020 | 08:56h | UTC

First line drug treatment for hypertension and reductions in blood pressure according to age and ethnicity: cohort study in UK primary care – The BMJ

Commentary: Study questions blood pressure drug guidance based on age and ethnicity – British Medical Journal AND Laurie Tomlinson: Shining a light into medicine’s dusty corners – The BMJ Opinion AND UK’s NICE Guidelines for Hypertension Tx Based on Age, Ethnicity May Need Updating – Physician’s Weekly AND

 

Commentary on Twitter

 


Randomized trial: Nebulized magnesium does not benefit children with acute refractory asthma treated in the emergency department

26 Nov, 2020 | 08:58h | UTC

Effect of Nebulized Magnesium vs Placebo Added to Albuterol on Hospitalization Among Children With Refractory Acute Asthma Treated in the Emergency Department: A Randomized Clinical Trial – JAMA (free for a limited period)

Commentary: Nebulized Magnesium Of Little Value for Emergency Tx of Kids’ Asthma Attacks – Physician’s Weekly

 

Commentary on Twitter

 


Cluster-randomized trial: Postexposure hydroxychloroquine does not prevent Covid-19 in healthy persons exposed to a PCR-positive case patient

25 Nov, 2020 | 09:15h | UTC

A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of Covid-19 – New England Journal of Medicine

 

Commentary on Twitter

 


With more data on its COVID-19 vaccine, Russian institute offers new evidence of success

25 Nov, 2020 | 09:13h | UTC

With more data on its COVID-19 vaccine, Russian institute offers new evidence of success – Science

News release: SECOND interim analysis of clinical trial data showed a 91.4% efficacy for the Sputnik V vaccine on day 28 after the first dose; vaccine efficacy is over 95% 42 days after the first dose – Sputnik V

Commentaries: Expert reaction to press release reporting the second interim analysis of the efficacy of the Sputnik V vaccine – Science Media Centre AND Russia says Sputnik V virus vaccine 95% effective – MedicalXpress

 


Latest COVID-19 guidelines come out against bamlanivimab, remdesivir

25 Nov, 2020 | 09:10h | UTC

Latest COVID-19 guidelines come out against bamlanivimab, remdesivir – ACP Internist

 


Systematic review: Financial payments from the pharmaceutical industry is associated with more physician prescribing of the drug made by the company that they got the payments from

25 Nov, 2020 | 09:07h | UTC

Are Financial Payments From the Pharmaceutical Industry Associated With Physician Prescribing? A Systematic Review – Annals of Internal Medicine (link to abstract – $ for full-text)

Commentary: Financial payments from drug industry associated with physician prescribing – American College of Physicians

 

Commentary from the author on Twitter  (thread – click for more)

 


Why does the AstraZeneca-Oxford COVID-19 vaccine’s efficacy vary so much? Here’s what we know

24 Nov, 2020 | 09:30h | UTC

Why Does the AstraZeneca COVID-19 Vaccine’s Efficacy Vary So Much? Here’s What We Know – TIME

Related: Why Oxford’s positive COVID vaccine results are puzzling scientists – Nature

 


Why the AstraZeneca-Oxford Covid-19 vaccine is different. It does not require extremely cold temperatures for storage, and the price will be “a fraction” of the expense of the other vaccine candidates

24 Nov, 2020 | 09:32h | UTC

Why the AstraZeneca-Oxford Covid-19 vaccine is different – Vox

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.